Peritoneal Dialysis-associated Peritonitis Caused by Chryseobacterium indologenes
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Chryseobacterium indologenes (C. indologenes) is a nonmotile, gram-negative bacillus that is widely distributed in nature. Generally considered nonpathogenic, C. indologenes rarely infects humans and is not normally present in the human microflora. C. indologenes infections have been observed in cases of peritoneal dialysis (PD)-associated peritonitis, although the incidence of these infections is low. Although C. indologenes is generally susceptible to trimethoprim-sulfamethoxazole, levofloxacin, ciprofloxacin, piperacillin-tazobactam, and cefepime, no guidelines have been established for the treatment of PD-associated peritonitis. Here we report the first case of PD-associated peritonitis in Korea with C. indologenes identified as the sole etiologic agent. The patient recovered after intraperitoneal antibiotic treatment without the need for Tenckhoff catheter removal.
Abstract
Chryseobacterium indologenes (C. indologenes) is a nonmotile, gram-negative bacillus that is widely distributed in nature. Generally considered nonpathogenic, C. indologenes rarely infects humans and is not normally present in the human microflora. C. indologenes infections have been observed in cases of peritoneal dialysis (PD)-associated peritonitis, although the incidence of these infections is low. Although C. indologenes is generally susceptible to trimethoprim-sulfamethoxazole, levofloxacin, ciprofloxacin, piperacillin-tazobactam, and cefepime, no guidelines have been established for the treatment of PD-associated peritonitis. Here we report the first case of PD-associated peritonitis in Korea with C. indologenes identified as the sole etiologic agent. The patient recovered after intraperitoneal antibiotic treatment without the need for Tenckhoff catheter removal.
참고문헌 (9)
- Troidle L, "Continuous peritoneal dialysis-associated peritonitis: a review and current concepts", Semin Dial, 16, pp.428~437 (2003)[DOI]
- Afshar M, "Chryseobacterium indologenes peritonitis in peritoneal dialysis", BMJ Case Rep, 2013, pp.bcr2013009410~ (2013)
- Hsueh PR, "Flavobacterium indologenes bacteremia: clinical and microbiological characteristics", Clin Infect Dis, 23, pp.550~555 (1996)[DOI]
- Lin YT, "Clinical and microbiological characteristics of Chryseobacterium indologenes bacteremia", J MicrobiolImmunol Infect, 43, pp.498~505 (2010)
- Vandamme P, "New perspectives in the classification of the flavobacteria: description of Chryseobacterium gen. nov., Bergeyella gen. nov., and Empedobacternom. rev", Int J Syst Bacteriol, 44, pp.827~831 (1994)[DOI]
- Hsueh PR, "Increasing incidence of nosocomial Chryseobacterium indologenes infections in Taiwan", Eur J Clin Microbiol Infect Dis, 16, pp.568~574 (1997)[DOI]
- 윤정수, "지속성 외래복막투석 환자에서 발생한 Chryseobacterium indologenes와 Sphingomonas paucimobilis복합균주에 의한 복막염 1예", Kidney Research and Clinical Practice, 26(6), pp.801~805 (2007), 대한신장학회
- Li PK, "Peritoneal dialysis-related infections recommendations: 2010 update", Perit Dial Int, 30, pp.393~423 (2010)[DOI]
- Kirby JT, "Antimicrobial susceptibility and epidemiology of a worldwide collection of Chryseobacteriumspp: report from the SENTRY Antimicrobial Surveillance Program (1997-2001)", J Clin Microbiol, 42, pp.445~448 (2004)[DOI]